This study describes the discovery and preclinical evaluation of MJ04, a novel small molecule inhibitor of JAK3 kinase, showing efficacy in a mouse model of androgenetic alopecia (AGA). MJ04 demonstrated potent JAK3 inhibitory activity in vitro and in vivo, leading to hair regrowth in the AGA model. Further studies investigated its pharmacokinetic properties and safety profile.
Publisher
Journal Name
Published On
Jan 01, 2024
Authors
Author 1 Name, Author 2 Name
Tags
MJ04
JAK3 kinase
androgenetic alopecia
hair regrowth
preclinical evaluation
pharmacokinetics
safety profile
Related Publications
Explore these studies to deepen your understanding of the subject.